Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.25
-0.05-1.16%
At close: Jul 16, 5:00 PM EST
$4.29
0.040.94%
After Hours: Jul 15, 7:03 PM EST
Exagen Inc Analyst Ratings
XGNNASDAQ
Exagen Analyst Ratings and Price Targets | NASDAQ:XGN | Benzinga
Exagen Inc has a consensus price target of $8.63 based on the ratings of 8 analysts. The high is $10 issued by Craig-Hallum on March 11, 2026. The low is $7 issued by Cantor Fitzgerald on May 15, 2025. The 3 most-recent analyst ratings were released by Roth Capital, BTIG, and Canaccord Genuity on June 25, 2026, May 12, 2026, and April 20, 2026, respectively. With an average price target of $8 between Roth Capital, BTIG, and Canaccord Genuity, there's an implied 86.48% upside for Exagen Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Roth Capital
BTIG
Canaccord Genuity
Craig-Hallum
Keybanc
1calculated from analyst ratings
Analyst Ratings for Exagen
Loading calendar...
FAQ
What is the target price for Exagen (XGN) stock?
The latest price target for Exagen (NASDAQ:XGN) was reported by Roth Capital on June 25, 2026. The analyst firm set a price target for $8.00 expecting XGN to rise to within 12 months (a possible 86.48% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Exagen (XGN)?
The latest analyst rating for Exagen (NASDAQ:XGN) was provided by Roth Capital, and Exagen initiated their buy rating.
When was the last upgrade for Exagen (XGN)?
The last upgrade for Exagen Inc happened on July 30, 2025 when Keybanc raised their price target to $12. Keybanc previously had a sector weight for Exagen Inc.
When was the last downgrade for Exagen (XGN)?
There is no last downgrade for Exagen.
When is the next analyst rating going to be posted or updated for Exagen (XGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exagen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exagen was filed on June 25, 2026 so you should expect the next rating to be made available sometime around June 25, 2027.
Is the Analyst Rating Exagen (XGN) correct?
While ratings are subjective and will change, the latest Exagen (XGN) rating was a initiated with a price target of $0.00 to $8.00. The current price Exagen (XGN) is trading at is $4.29, which is within the analyst’s predicted range.
